VRCA Key Financial Ratios - Verrica Pharmaceuticals Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	1.45	—	-86.58%	-724.01%
2026-03-31	2.1	—	-45.96%	-111.03%
2025-12-31	2.59	0	-37.95%	-72.29%
2025-09-30	1.25	-2	-63.61%	152.66%
2025-06-30	1.26	-2.13	-124.27%	277.97%
2025-03-31	1.34	-2.19	-156.46%	355.24%
2024-12-31	1.76	-4.45	-141.46%	776.66%
2024-09-30	1.34	—	-258.12%	249.60%
2024-06-30	2.36	—	-167.15%	653.63%
2024-03-31	3.17	—	-121.76%	-5353.91%
2023-12-31	4.55	2.17	-82.10%	-338.99%
2023-09-30	8.06	—	-49.73%	-114.21%
2023-06-30	9.91	—	-37.66%	-42.29%
2023-03-31	23.87	—	-32.93%	-34.86%
2022-12-31	11.31	0	-54.76%	-61.17%
2022-09-30	14.1	—	-57.17%	-62.76%
2022-06-30	1.25	—	-64.64%	-251.07%
2022-03-31	1.47	—	-59.50%	-167.65%
2021-12-31	1.61	—	-43.78%	-107.59%
2021-09-30	1.79	—	-43.40%	-94.28%
2021-06-30	2.06	—	-36.53%	-69.36%
2021-03-31	2.29	—	-31.27%	-54.70%
2020-12-31	1.71	—	-57.57%	-129.43%
2020-09-30	1.9	—	-46.73%	-95.33%
2020-06-30	2.15	—	-37.78%	-68.01%
2020-03-31	27.45	—	-32.35%	-53.97%
2019-12-31	19.39	—	-41.22%	-43.39%
2019-09-30	17.1	—	-37.00%	-39.28%
2019-06-30	18.63	—	-34.42%	-36.39%
2019-03-31	27.65	—	-30.57%	-31.75%
2018-12-31	36.8	—	-22.47%	-23.09%
2018-09-30	40.26	—	-14.68%	-15.05%
2018-06-30	33.47	—	-9.51%	-9.80%
2018-03-31	—	—	—	65.53%
2017-12-31	14.75	—	—	—

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	2.59	0	-37.95%	-72.29%
2024-12-31	1.76	-4.45	-141.46%	776.66%
2023-12-31	4.55	2.17	-82.10%	-338.99%
2022-12-31	11.31	0	-54.76%	-61.17%
2021-12-31	1.61	—	-43.78%	-107.59%
2020-12-31	1.71	—	-57.57%	-129.43%
2019-12-31	19.39	—	-41.22%	-43.39%
2018-12-31	36.8	—	-22.47%	-23.09%
2017-12-31	14.75	—	-49.09%	63.33%